 |
|
|
|
|
|
|
|
|
|
|
|
1 to 10 of 10 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Zheng H. on PAPER: Freude KK. et al., 2011, This paper presents two interesting findings. One is that expression of APP in human embryonic... 8 Jun 2011.
|
|
|
 |
|
|
Zheng H. on NEWS: Keystone: Death Receptor Ligand—New Role for APP, New Model for AD?, The paper from Marc Tessier-Lavigne and colleagues provides compelling evidence that DR6... 26 Feb 2009.
|
|
|
|
|
|
Zheng H. on PAPER: Zhang YW. et al., 2007, The work by Zhang et al. provides compelling evidence that APP, through presenilin-dependent... 26 Jun 2007.
|
|
|
|
|
|
Zheng H. on PAPER: Kim J. et al., 2007, This report unequivocally demonstrates that Aβ40 and Aβ42 peptides have opposite effects on... 30 Jan 2007.
|
|
|
|
|
|
Zheng H. on LIVE DISCUSSION: Gain or Loss of Function—Time to Shake up Assumptions on γ-Secretase in Alzheimer Disease?, The two papers cited above employ the use of cell cultures and human samples to study the... 6 Apr 2006.
|
|
|
|
|
|
Zheng H. on PAPER: Lazarov O. et al., 2005, Having read this paper, Larry Goldstein's paper,... 7 Apr 2005.
|
|
|
|
|
|
Zheng H. on NEWS: Target BACE: Better Than Ever?, Ohno et al. bred the BACE1 knockout (BACE1-/-) mice onto the Tg2576 APP transgenic background... 12 Jan 2004.
|
|
|
|
|
|
Zheng H. on NEWS: Nicastrin Mutations Selectively Modulate Notch Processing, Using genetic cross-breeding, Rozmahel et al. presented a novel finding that the presenilin 1... 18 Oct 2002.
|
|
|
|
|
|
Zheng H. on NEWS: "Cat"egorical Evidence for Presenilin's Proteolytic Role?, Reply by Hui Zheng
Dr. Sisodia challenged our data that hPS1D257A is negative in Notch and... 23 Jun 2002.
|
|
|
|
|
|
Zheng H. on NEWS: "Cat"egorical Evidence for Presenilin's Proteolytic Role?, Reply by Hui Zheng
Dr. Sisodia challenged our data that hPS1D257A is negative in... 23 Jun 2002.
|
|
|
|
|
|
|
1 to 10 of 10 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
See our latest Webinar: 
